News | Alzheimer's Prevention Registry

You are here

News

Come back regularly for the latest news and information about Alzheimer’s disease and prevention.

The Alzheimer’s Clinical Trials Consortium (ACTC) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the investigational oral BACE (beta amyloid cleaving enzyme...
Every month, a car would pick up Jeff Borghoff at his home in Forked River, New Jersey, and drive him to the Advanced Memory Research Institute of New Jersey. There, doctors would help him settle...
I was a small piece in the search to find a cure. Now I feel as if I’m getting erased, and medical science doesn’t have any answers.
Clinical trial participants, researchers and investors were reeling on Thursday after Biogen and Eisai, its Japanese pharmaceutical partner, announced that they would be halting two Stage 3...
January 1, 2019
by ALZFORUM
Once again, it’s time to reflect on the preceding 12 months. Despite the 2025 deadline for effective therapy that has been set by the National Alzheimer’s Plan and the World Dementia Council, 2018...
You may have heard of the ambitious goal set by the U.S. National Plan to Address Alzheimer’s Disease – to prevent and effectively treat Alzheimer’s disease by 2025. While this plan offers great...
April 2, 2018
by MD Magazine
Currently, several trials are trying to develop therapies for AD by 2025. These trials’ success, however, depends upon participants who are willing to undergo genetic and biomarker testing to learn...
Married for more than 50 years, the Woodings are among the more than 5 million Americans who are facing Alzheimer’s disease, one of the most devastating diagnoses today. But instead of accepting the...
Researchers hope the test will help with drug trials and early intervention
Merck & Co. will stop its final-stage test of an Alzheimer’s compound that was once seen as a promising alternative to other now-failed approaches.Merck & Co. will stop its final-...